Hims & Hers Health, Inc.

Hims & Hers Health, Inc. (NYSE: HIMS) went public through a business combination with Oaktree Acquisition Corp, a blank-check vehicle sponsored by Oaktree Capital Management, with the merger closing in January 2021. Oaktree Acquisition Corp priced its IPO in 2020, targeting the consumer health and telehealth sector. The Form 10-Q filed November 13, 2020 — accession 0001193125-20-291907 — reflects the company's financial position during the pre-close period of the de-SPAC transaction. Hims & Hers operates a direct-to-consumer telehealth platform offering prescription treatments and wellness products spanning sexual health, dermatology, and mental health. Sign up on SpacDesk for complete filing history and data coverage on HIMS and thousands of other SPAC transactions.